...
首页> 外文期刊>The Internet Journal of Infectious Diseases >Hepatitis C Virus Co-Infection In Human Immuno Deficiency Virus Positive Population In Bida, North Central Nigeria.
【24h】

Hepatitis C Virus Co-Infection In Human Immuno Deficiency Virus Positive Population In Bida, North Central Nigeria.

机译:尼日利亚中北部比达的人类免疫缺陷病毒阳性人群中的丙型肝炎病毒共感染。

获取原文

摘要

Co-infection of HIV–positive patients with hepatitis viruses worsens the long term prognosis and this is summative for each new infection in any individual.This study was carried out to establish the seroprevalence of hepatitis C virus among HIV infected population in Bida –North Central Nigeria. A total of 250 HIV –infected patients 119 males and 131females paticipated in this study with age range of 18-65years .Rapid Chromatogenic Enzyme Immuno Assay (EIA) kit was used for the detection of HCV antibodies in the serum samples. Nineteen (7.6%) of the patients had antibodies to HCV. Co-infection of hepatitis are more in male 10( 8.4%) than female 9(6.9%) subjects.Statistical analysis showed no significant difference(p>0.05) Age group 41-50years had the highest prevalence of HCV (50.7%) followed by age group 31-40 years (16.5%) , 21-30years ( 9.9%) and <20years(6.7%).No significant difference was observed in association between age and prevalence of HCV antibodies(p>0.05) .Routine screening of patients with HIV infection for HCV antibodies should be encouraged for early diagnosis.The high prevalence is a cause for concern in Bida, North central Nigeria. Introduction Human immuno deficency virus (HIV) and Hepatitis B and C viruses (HBV and HCV) are the three most comon chronic viral infection documented world wide (1). In patients already infected with HIV and either hepatitis B or C, the prognosis is made much worse with additional infection by other hepatotropic viruses (2). The viruses has similar route of transmission, namely through blood and blood products, sharing of needles to inject drugs and sexual activity, enabling co-infection with these viruses a common event (3). HIV positive individuals are at risk of co-infection with HBV and HCV infection (4). With the advent of highly active antiretroviral therapy (HAART) regime capable of dramatically prolonging the survival of HIV infected patients, the impact of co-morbid infections such as HBV and HCV has come into focus (5). Co-infection with HCV increases the risk for hepatotoxicity of HAART and likelihood of onset of an AIDS-defining illness, compared with infection HIV-1 alone (6). HCV co- infection in HIV positive individuals is of utmost importance due to the underlying consequences such as the hepatological problem associated with these viruses, which have been shown to decrease the life expectancy in HIV infected patients (7). HIV accounts for 38.6million infections world wide at the end of 2005(8). While HCV accounts for 17million chronic infection (9,10). Moreover among the HIV infected patients, 4-5 million are co-infected with HCV(9). Nigeria belongs to the group of countries highly endemic for viral hepatitis(11). The knowledge about the interrelationship between HIV and HCV and their effect on the immune system remains unclear in Bida North central Nigeria as no study of this nature has been done.This study was therefore carried out to estimate the prevalence of HCV seropositivity in patients living with HIV/AIDS in Bida –Niger State, North Central Nigeria . Materials And Methods A prospective Cross sectional and analytical study was carried out at the Federal Medical Centre Bida. Only confirmed HIV positive serum samples were included in this study.Two hundred and fifty (250) samples were recalled randomly from a pool of confirmed HIV positive samples stored at -24oC until analysis. The samples were collected between January 2009-July 2010 from HIV seropositive patients who attended HAART clinic for follow –up and other health needs. Rapid chromatogenic Ezyme Immuno Assay (EIA) kits was used for the detection of anti HCV in the serum following the manufacturers instruction. (Acummen Diagnostics Inc.USA. ) Hapatitis C positive samples were confirmed with a second serum based EIA rapid test (PMC Medical Pvt. Ltd India.). The EIA rapid test kit used had sensitivity of 99% and 99% specificity respectively and a positive predictive value of 99%. Statistical Analys
机译:HIV阳性患者与肝炎病毒的合并感染会使长期预后恶化,这对于任何一个人的每一次新感染都是总结性的。这项研究旨在确定中部地区比达北部的HIV感染人群中丙型肝炎病毒的血清阳性率。尼日利亚。该研究共纳入250例HIV感染患者,其中119名男性和131名女性,年龄在18-65岁之间。使用快速发色酶免疫测定(EIA)试剂盒检测血清样品中的HCV抗体。 19名(7.6%)患者具有抗HCV的抗体。男性10例(8.4%)的肝炎合并感染率高于女性9例(6.9%)。统计分析无显着性差异(p> 0.05)41-50岁年龄组的HCV患病率最高(50.7%),其次年龄组分别为31-40岁(16.5%),21-30岁(9.9%)和<20岁(6.7%)。年龄和HCV抗体患病率之间的相关性没有显着差异(p> 0.05)。应当鼓励HIV感染者感染HCV抗体的患者进行早期诊断。高流行是尼日利亚中北部比达(Bida)引起关注的原因。引言人类免疫缺陷病毒(HIV)和乙型和丙型肝炎病毒(HBV和HCV)是全世界记录的三种最常见的慢性病毒感染(1)。在已经感染了艾滋病毒和乙型或丙型肝炎的患者中,其他肝炎病毒的额外感染使预后变得更糟(2)。病毒具有相似的传播途径,即通过血液和血液制品,共用针头以注射药物和进行性活动,从而使这些病毒共同感染成为常见事件(3)。 HIV阳性个体有同时感染HBV和HCV感染的风险(4)。随着高活性抗逆转录病毒疗法(HAART)能够显着延长感染HIV的患者的生存期,出现了诸如HBV和HCV等合并症感染的影响(5)。与单独感染HIV-1相比,与HCV合并感染会增加HAART发生肝毒性的风险,并增加定义艾滋病的疾病的可能性(6)。由于诸如病毒相关的肝病等潜在后果,已导致HIV感染患者的预期寿命降低,因此其在HCV阳性患者中的HCV共感染至关重要。(7)到2005年底,全球HIV感染人数为3860万(8)。 HCV占1700万慢性感染(9,10)。此外,在感染了HIV的患者中,有4-5百万人被HCV合并感染(9)。尼日利亚属于病毒性肝炎高度流行的国家组(11)。在尼日利亚中北部的比达,关于HIV和HCV之间的相互关系及其对免疫系统影响的相关知识尚不清楚,因为尚未进行这种性质的研究,因此进行了这项研究以评估患有HCV的患者中HCV血清阳性的患病率尼日利亚中北部比达–尼日尔州的艾滋病毒/艾滋病。材料和方法在比达联邦医学中心进行了前瞻性的横截面和分析研究。本研究仅包括确诊的HIV阳性血清样本。从-24oC储存的确诊的HIV阳性样本池中随机抽取了250(250)个样本,直至进行分析。这些样本是在2009年1月至2010年7月之间从艾滋病毒血清阳性患者中收集的,这些患者前往HAART诊所进行随访和其他健康需求。按照制造商的说明,使用快速发色酶免疫测定(EIA)试剂盒检测血清中的抗HCV。 (美国Acummen Diagnostics Inc.)已通过第二次基于血清的EIA快速检测(印度PMC Medical Pvt。Ltd.)确认了丙型肝炎阳性样品。使用的EIA快速检测试剂盒的敏感性分别为99%和99%,阳性预测值为99%。统计分析

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号